149 related articles for article (PubMed ID: 9575241)
1. Monoamine oxidase B single-photon emission tomography with [123I]Ro 43-0463: imaging in volunteers and patients with temporal lobe epilepsy.
Buck A; Frey LD; Bläuenstein P; Krämer G; Siegel A; Weber B; Schubiger PA; Wieser HG
Eur J Nucl Med; 1998 May; 25(5):464-70. PubMed ID: 9575241
[TBL] [Abstract][Full Text] [Related]
2. [123I/125I]-Ro 43-0463, a site specific tracer for MAO-B mapping with autoradiography as well as with SPET.
Beer HF; Frey LD; Rossetti I; Remy N; Maier A; Schubiger PA
J Recept Signal Transduct Res; 1995; 15(1-4):581-93. PubMed ID: 8903965
[TBL] [Abstract][Full Text] [Related]
3. Presurgical identification of epileptic foci with iodine-123 iomazenil SPET: comparison with brain perfusion SPET and FDG PET.
Tanaka F; Yonekura Y; Ikeda A; Terada K; Mikuni N; Nishizawa S; Ishizu K; Okazawa H; Hattori N; Shibasaki H; Konishi J; Onishi Y
Eur J Nucl Med; 1997 Jan; 24(1):27-34. PubMed ID: 9044873
[TBL] [Abstract][Full Text] [Related]
4. In vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B.
Bläuenstein P; Rémy N; Buck A; Ametamey S; Häberli M; Schubiger PA
Nucl Med Biol; 1998 Jan; 25(1):47-52. PubMed ID: 9466361
[TBL] [Abstract][Full Text] [Related]
5. 123I-labeling and evaluation of Ro 43-0463, a SPET tracer for MAO-B imaging.
Beer HF; Rossetti I; Frey LD; Hasler PH; Schubiger PA
Nucl Med Biol; 1995 Oct; 22(7):929-936. PubMed ID: 8547891
[TBL] [Abstract][Full Text] [Related]
6. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
Bench CJ; Price GW; Lammertsma AA; Cremer JC; Luthra SK; Turton D; Dolan RJ; Kettler R; Dingemanse J; Da Prada M
Eur J Clin Pharmacol; 1991; 40(2):169-73. PubMed ID: 1906004
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.
Fowler JS; Volkow ND; Logan J; Schlyer DJ; MacGregor RR; Wang GJ; Wolf AP; Pappas N; Alexoff D; Shea C
Neurology; 1993 Oct; 43(10):1984-92. PubMed ID: 8413955
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of radioiodinated MD-230254: a new ligand for potential imaging of monoamine oxidase B activity by single photon emission computed tomography.
Hirata M; Kagawa S; Yoshimoto M; Ohmomo Y
Chem Pharm Bull (Tokyo); 2002 May; 50(5):609-14. PubMed ID: 12036014
[TBL] [Abstract][Full Text] [Related]
9. [123I/18F] N-(2-aminoethyl)-5-halogeno-2-pyridinecarbox-amides, site specific tracers for MAO-B mapping with SPECT and PET.
Beer HF; Frey LD; Häberli M; Schubiger PA
Nucl Med Biol; 1995 Nov; 22(8):999-1004. PubMed ID: 8998478
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy.
Kumlien E; Bergström M; Lilja A; Andersson J; Szekeres V; Westerberg CE; Westerberg G; Antoni G; Långström B
Epilepsia; 1995 Jul; 36(7):712-21. PubMed ID: 7555990
[TBL] [Abstract][Full Text] [Related]
11. Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging).
Mohamed A; Eberl S; Fulham MJ; Kassiou M; Zaman A; Henderson D; Beveridge S; Constable C; Lo SK
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):180-5. PubMed ID: 15449046
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase B inhibitor, selegiline, reduces
Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
[TBL] [Abstract][Full Text] [Related]
13. Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography.
Lammertsma AA; Bench CJ; Price GW; Cremer JE; Luthra SK; Turton D; Wood ND; Frackowiak RS
J Cereb Blood Flow Metab; 1991 Jul; 11(4):545-56. PubMed ID: 1904879
[TBL] [Abstract][Full Text] [Related]
14. In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.
Freedman NM; Mishani E; Krausz Y; Weininger J; Lester H; Blaugrund E; Ehrlich D; Chisin R
J Nucl Med; 2005 Oct; 46(10):1618-24. PubMed ID: 16204711
[TBL] [Abstract][Full Text] [Related]
15. Imaging monoamine oxidase B receptor mapping.
Reutens DC
Adv Neurol; 2000; 83():173-6. PubMed ID: 10999199
[No Abstract] [Full Text] [Related]
16. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).
Nag S; Lehmann L; Kettschau G; Toth M; Heinrich T; Thiele A; Varrone A; Halldin C
Bioorg Med Chem; 2013 Nov; 21(21):6634-41. PubMed ID: 24012376
[TBL] [Abstract][Full Text] [Related]
17. Temporal lobe epilepsy visualized with PET with 11C-L-deuterium-deprenyl--analysis of kinetic data.
Bergström M; Kumlien E; Lilja A; Tyrefors N; Westerberg G; Långström B
Acta Neurol Scand; 1998 Oct; 98(4):224-31. PubMed ID: 9808270
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy.
Lee JD; Kim HJ; Lee BI; Kim OJ; Jeon TJ; Kim MJ
Eur J Nucl Med; 2000 Nov; 27(11):1658-65. PubMed ID: 11105822
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).
Nag S; Lehmann L; Kettschau G; Heinrich T; Thiele A; Varrone A; Gulyas B; Halldin C
Bioorg Med Chem; 2012 May; 20(9):3065-71. PubMed ID: 22436387
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and estimated radiation burden for a new 123I-labelled monoamine oxidase-B inhibitor, Ro 43-0463: a preliminary report.
Hasler PH; Beer HF; Frey L; Rossetti I; Schubiger PA
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):59-62. PubMed ID: 7632769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
